
Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia
CK Law et al, Genetics in Medicine, August 30, 2023
Cost effectiveness review of text messaging, smartphone application, and website interventions targeting T2DM or hypertension.
Ruben Willems et al. NPJ Digit Med 2023 8 (1) 150
AI-based skin cancer detection: the balance between access and overutilization
KP Venkatesh et al, NPJ Digital Medicine, August 15, 2023
The English National Lynch Syndrome Transformation Project
Brit Soc Gastro, July 14, 2023


Gábor Kovács et al. Per Med 2023
Economic evaluations of artificial intelligence-based healthcare interventions: a systematic literature review of best practices in their conduct and reporting.

Jai Vithlani et al. Front Pharmacol 2023 141220950
Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.

et al. Ont Health Technol Assess Ser 2023 23(4) 1-398
Cost-effectiveness of preventive aspirin use and intensive downstaging polypectomy in patients with familial adenomatous polyposis: A microsimulation modeling study.

Eiko Saito et al. Cancer Med 2023
Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada.

Aneeka Hafeez et al. Pharmacoeconomics 2023
Economic evaluations of predictive genetic testing: A scoping review.

Qin Xi et al. PLoS One 2023 18(8) e0276572
Implementation and Feasibility of Clinical Genome Sequencing Embedded Into the Outpatient Nephrology Care for Patients With Proteinuric Kidney Disease.

Maddalena Marasa et al. Kidney Int Rep 2023 8(8) 1638-1647
Molecular testing for indeterminate thyroid nodules: past, present, and future.

Rajam Raghunathan et al. Curr Opin Endocrinol Diabetes Obes 2023
Cost-effectiveness analysis of implementing polygenic risk score in a workplace cardiovascular disease prevention program.

Deo Mujwara et al. Front Public Health 2023 111139496
Genomic testing for suspected monogenic kidney disease in children and adults: a health economic evaluation.

You Wu et al. Genet Med 2023 100942
More
About Economic Evaluation PHGKB
Economic Evaluation PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that identify, measure, value, and compare the costs and consequences of genomic and other precision health interventions, policies and programs. Economic Evaluation PHGKB is a specialized database of the overall PHGKB.
Content Summary
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 22, 2023
- Content source: